|
|
||||||||
Biochemistry |
Laboratoire de Recherche Moléculaire sur les Antibiotiques (LRMA), Université Pierre et Marie Curie (Paris VI), Faculté de Médecine Pitié-Salpêtrière, 91 Bd de lHôpital, 75634 Paris Cédex 13, France1
LRMA, Faculté de Médecine, Broussais-Hôtel Dieu, 75005 Paris, France2
Author for correspondence: Wladimir Sougakoff. Tel: +33 1 40 77 97 46. Fax: +33 1 45 82 75 77. e-mail: sougakof@ lmcp.jussieu.fr
The DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum, which are species naturally resistant, moderately susceptible and susceptible to fluoroquinolones, respectively, were purified by affinity chromatography on novobiocin-Sepharose columns. The DNA gyrase inhibiting activities (IC50 values) of classical quinolones and fluoroquinolones were determined from the purified enzymes and were compared to the corresponding antibacterial activities (MICs). Regarding M. fortuitum bv. peregrinum, which is nearly as susceptible as Escherichia coli, the corresponding MIC and IC50 values of quinolones were significantly lower than those found for M. avium and M. smegmatis (e.g. for ofloxacin, MICs of 0·25 versus 32 and 1 µg ml-1, and IC50 values of 1 versus 8 and 6 µg ml-1, respectively). Such a result could be related to the presence of Ser-83 in the quinolone-resistance-determining region of the gyrase A subunit of M. fortuitum bv. peregrinum, as found in wild-type E. coli, instead of Ala-83 in M. avium and M. smegmatis, as found in fluoroquinolone-resistant E. coli mutants. The IC50 values of quinolones against the M. avium and M. smegmatis DNA gyrases were similar, while the corresponding MICs were 32-fold higher for M. avium when compared to M. smegmatis, suggesting that an additional mechanism, such as a low cell wall permeability or a drug efflux, could contribute to the low antibacterial potency of quinolones against M. avium.
Keywords: Mycobacterium, DNA gyrase, quinolone inhibition assays, fluoroquinolone resistance
Abbreviations: QRDR, quinolone-resistance-determining regions
This article has been cited by other articles:
![]() |
S. Matrat, A. Aubry, C. Mayer, V. Jarlier, and E. Cambau Mutagenesis in the {alpha}3{alpha}4 GyrA Helix and in the Toprim Domain of GyrB Refines the Contribution of Mycobacterium tuberculosis DNA Gyrase to Intrinsic Resistance to Quinolones Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2909 - 2914. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aubry, N. Veziris, E. Cambau, C. Truffot-Pernot, V. Jarlier, and L. M. Fisher Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis: Functional Analysis of Mutant Enzymes Antimicrob. Agents Chemother., January 1, 2006; 50(1): 104 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aubry, X.-S. Pan, L. M. Fisher, V. Jarlier, and E. Cambau Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug Activity Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1281 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chatterji, S. Unniraman, S. Mahadevan, and V. Nagaraja Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis J. Antimicrob. Chemother., October 1, 2001; 48(4): 479 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, X. Zhao, X. Li, A. Drlica-Wagner, J.-Y. Wang, J. Domagala, and K. Drlica Enhancement of Fluoroquinolone Activity by C-8 Halogen and Methoxy Moieties: Action against a Gyrase Resistance Mutant of Mycobacterium smegmatis and a Gyrase-Topoisomerase IV Double Mutant of Staphylococcus aureus Antimicrob. Agents Chemother., October 1, 2001; 45(10): 2703 - 2709. [Abstract] [Full Text] |
||||
![]() |
Y. Onodera, M. Tanaka, and K. Sato Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis J. Antimicrob. Chemother., April 1, 2001; 47(4): 447 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Poole Efflux-Mediated Resistance to Fluoroquinolones in Gram-Positive Bacteria and the Mycobacteria Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2595 - 2599. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |